STORY: In a small refrigerator at the Kivu Diabetes Centre in Bukavu, eastern Congo,
Dr. Albert Kalehezo carefully guards his dwindling supply of insulin, each vial a lifeline for diabetic patients.
He says the shortage is a direct consequence of the renewed violence in eastern Congo.
“Since the current crisis, access to insulin has been difficult. Even before, insulin access was expensive. For these children, I prescribe treatment, but they are not able to obtain it.”
The M23 rebel group, allegedly backed by Rwanda, has intensified its operations in Congo since January,
seizing control of key cities, displacing thousands and disrupting vital supply chains.
The closure of Goma airport, a crucial hub for medicine shipments, has left healthcare providers scrambling.
Kalehezo now travels to neighboring Rwanda to procure supplies, though these efforts often fall short.
The crisis extends beyond the diabetes center.
Local pharmacies report severe shortages and skyrocketing prices.
This pharmacist, who requested anonymity out of fear of retaliation from the M23, said prices across the drug market were ”exorbitant”.
Even when alternative brands were found, customers wouldn’t buy it, she said.
The insulin crisis is one facet of the broader humanitarian emergency unfolding in eastern Congo.
In July, the United Nations reported at least 319 civilian deaths in Rutshuru at the hands of M23 fighters.
